IL12RB1 and neoplasm: In D35 tumor-bearing mice treated with IL-12R−/− CAR T cells, the survival advantage conferred by 4H1128ζ-IL12 was lost (Fig. 2b), underscoring the significance of IL-12 autocrine activity on 4H1128ζ-IL12 T cells in promoting survival.